Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,419
archived clinical trials in
Pulmonary

Study of the Effect of VX-770 on Lung Clearance Index in Subjects With Cystic Fibrosis and the G551D Mutation
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Effect of VX-770 on Lung Clearance Index in Subjects With Cystic Fibrosis, the G551D Mutation, and FEV1 >90% Predicted
Status: Archived
Clinical Trial Facility
mi
from
Santa Clara, CA
Study of the Effect of VX-770 on Lung Clearance Index in Subjects With Cystic Fibrosis and the G551D Mutation
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Effect of VX-770 on Lung Clearance Index in Subjects With Cystic Fibrosis, the G551D Mutation, and FEV1 >90% Predicted
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Santa Clara, CA
Study of the Effect of VX-770 on Lung Clearance Index in Subjects With Cystic Fibrosis and the G551D Mutation
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Effect of VX-770 on Lung Clearance Index in Subjects With Cystic Fibrosis, the G551D Mutation, and FEV1 >90% Predicted
Status: Archived
Clinical Trial Facility
mi
from
Bettendorf, IA
Study of the Effect of VX-770 on Lung Clearance Index in Subjects With Cystic Fibrosis and the G551D Mutation
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Effect of VX-770 on Lung Clearance Index in Subjects With Cystic Fibrosis, the G551D Mutation, and FEV1 >90% Predicted
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Bettendorf, IA
Study of the Effect of VX-770 on Lung Clearance Index in Subjects With Cystic Fibrosis and the G551D Mutation
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Effect of VX-770 on Lung Clearance Index in Subjects With Cystic Fibrosis, the G551D Mutation, and FEV1 >90% Predicted
Status: Archived
Clinical Trial Facility
mi
from
Charlotte, NC
Study of the Effect of VX-770 on Lung Clearance Index in Subjects With Cystic Fibrosis and the G551D Mutation
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Effect of VX-770 on Lung Clearance Index in Subjects With Cystic Fibrosis, the G551D Mutation, and FEV1 >90% Predicted
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Charlotte, NC
Study of the Effect of VX-770 on Lung Clearance Index in Subjects With Cystic Fibrosis and the G551D Mutation
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Effect of VX-770 on Lung Clearance Index in Subjects With Cystic Fibrosis, the G551D Mutation, and FEV1 >90% Predicted
Status: Archived
Clinical Trial Facility
mi
from
Philadelphia, PA
Study of the Effect of VX-770 on Lung Clearance Index in Subjects With Cystic Fibrosis and the G551D Mutation
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Effect of VX-770 on Lung Clearance Index in Subjects With Cystic Fibrosis, the G551D Mutation, and FEV1 >90% Predicted
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Philadelphia, PA
Segmental Bronchoalveolar Lavage
Bronchoscopy in Patients With Pulmonary Diseases and Research Volunteers
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Segmental Bronchoalveolar Lavage
Bronchoscopy in Patients With Pulmonary Diseases and Research Volunteers
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Role of Toxins in Lung Infections Caused by Pseudomonas Aeruginosa
Role of Exotoxins in the Pathogenesis of Pseudomonas Aeruginosa
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Role of Toxins in Lung Infections Caused by Pseudomonas Aeruginosa
Role of Exotoxins in the Pathogenesis of Pseudomonas Aeruginosa
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Gene Modifiers of Cystic Fibrosis Lung Disease
Gene Modifiers of Cystic Fibrosis Lung Disease
Status: Enrolling
Updated:  12/31/1969
CTRC
mi
from
Chapel Hill, NC
Gene Modifiers of Cystic Fibrosis Lung Disease
Gene Modifiers of Cystic Fibrosis Lung Disease
Status: Enrolling
Updated: 12/31/1969
CTRC
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
The Role of Bacteria and Genetic Variations in Cystic Fibrosis
Clinical Course in Cystic Fibrosis: The Effects of Pseudomonas Aeruginosa and Potential Modifier Genes
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
The Role of Bacteria and Genetic Variations in Cystic Fibrosis
Clinical Course in Cystic Fibrosis: The Effects of Pseudomonas Aeruginosa and Potential Modifier Genes
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
The Role of Bacteria and Genetic Variations in Cystic Fibrosis
Clinical Course in Cystic Fibrosis: The Effects of Pseudomonas Aeruginosa and Potential Modifier Genes
Status: Enrolling
Updated:  12/31/1969
Univ of Washington
mi
from
Seattle, WA
The Role of Bacteria and Genetic Variations in Cystic Fibrosis
Clinical Course in Cystic Fibrosis: The Effects of Pseudomonas Aeruginosa and Potential Modifier Genes
Status: Enrolling
Updated: 12/31/1969
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
The Role of Bacteria and Genetic Variations in Cystic Fibrosis
Clinical Course in Cystic Fibrosis: The Effects of Pseudomonas Aeruginosa and Potential Modifier Genes
Status: Enrolling
Updated:  12/31/1969
University of Wisconsin
mi
from
Madison, WI
The Role of Bacteria and Genetic Variations in Cystic Fibrosis
Clinical Course in Cystic Fibrosis: The Effects of Pseudomonas Aeruginosa and Potential Modifier Genes
Status: Enrolling
Updated: 12/31/1969
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
The Role of Bacteria and Genetic Variations in Cystic Fibrosis
Clinical Course in Cystic Fibrosis: The Effects of Pseudomonas Aeruginosa and Potential Modifier Genes
Status: Enrolling
Updated:  12/31/1969
Medical College of Wisconsin
mi
from
Milwaukee, WI
The Role of Bacteria and Genetic Variations in Cystic Fibrosis
Clinical Course in Cystic Fibrosis: The Effects of Pseudomonas Aeruginosa and Potential Modifier Genes
Status: Enrolling
Updated: 12/31/1969
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Modafinil and Naltrexone to Reduce Cocaine and Alcohol Dependence
A Phase II, Double-blind, Placebo-Controlled, Pilot Trial of the Combination of Modafinil and Naltrexone for the Treatment of Cocaine and Alcohol Dependence
Status: Enrolling
Updated:  12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
Modafinil and Naltrexone to Reduce Cocaine and Alcohol Dependence
A Phase II, Double-blind, Placebo-Controlled, Pilot Trial of the Combination of Modafinil and Naltrexone for the Treatment of Cocaine and Alcohol Dependence
Status: Enrolling
Updated: 12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Airway Clearance for Prevention of Chronic Obstructive Pulmonary Disease (COPD) Exacerbation
A Randomized, Sham-controlled, Double-blinded Pilot Study to Assess the Effects of High Frequency Chest Wall Oscillation (HFCWO) Therapy in Patients With Chronic Bronchitis
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Asthma and Allergy Center
mi
from
Baltimore, MD
Airway Clearance for Prevention of Chronic Obstructive Pulmonary Disease (COPD) Exacerbation
A Randomized, Sham-controlled, Double-blinded Pilot Study to Assess the Effects of High Frequency Chest Wall Oscillation (HFCWO) Therapy in Patients With Chronic Bronchitis
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Asthma and Allergy Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Pharmacotherapy Dosing Regimen in Cocaine and Opiate Dependent Individuals - 8
Pharmacotherapy Dosing Regimen in Cocaine and Opiate Dependent Individuals
Status: Enrolling
Updated:  12/31/1969
University of Texas Health Science Center
mi
from
Houston, TX
Pharmacotherapy Dosing Regimen in Cocaine and Opiate Dependent Individuals - 8
Pharmacotherapy Dosing Regimen in Cocaine and Opiate Dependent Individuals
Status: Enrolling
Updated: 12/31/1969
University of Texas Health Science Center
mi
from
Houston, TX
Click here to add this to my saved trials
Effectiveness of N-Acetylcysteine (NAC) in Treating Cocaine Dependent Individuals - 1
A Controlled Trial of N-Acetylcysteine (NAC) for Cocaine Dependence
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Effectiveness of N-Acetylcysteine (NAC) in Treating Cocaine Dependent Individuals - 1
A Controlled Trial of N-Acetylcysteine (NAC) for Cocaine Dependence
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Behavioral & Nutritional Treatment to Help CF Preschoolers Grow
A Multi-Site Randomized Clinical Trial of Behavioral and Nutrition Treatment Designed to Help Preschoolers With Cystic Fibrosis Optimize Growth
Status: Enrolling
Updated:  12/31/1969
University of Arizona
mi
from
Tucson, AZ
Behavioral & Nutritional Treatment to Help CF Preschoolers Grow
A Multi-Site Randomized Clinical Trial of Behavioral and Nutrition Treatment Designed to Help Preschoolers With Cystic Fibrosis Optimize Growth
Status: Enrolling
Updated: 12/31/1969
University of Arizona
mi
from
Tucson, AZ
Click here to add this to my saved trials
Behavioral & Nutritional Treatment to Help CF Preschoolers Grow
A Multi-Site Randomized Clinical Trial of Behavioral and Nutrition Treatment Designed to Help Preschoolers With Cystic Fibrosis Optimize Growth
Status: Enrolling
Updated:  12/31/1969
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Behavioral & Nutritional Treatment to Help CF Preschoolers Grow
A Multi-Site Randomized Clinical Trial of Behavioral and Nutrition Treatment Designed to Help Preschoolers With Cystic Fibrosis Optimize Growth
Status: Enrolling
Updated: 12/31/1969
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Behavioral & Nutritional Treatment to Help CF Preschoolers Grow
A Multi-Site Randomized Clinical Trial of Behavioral and Nutrition Treatment Designed to Help Preschoolers With Cystic Fibrosis Optimize Growth
Status: Enrolling
Updated:  12/31/1969
University of Michigan Health System
mi
from
Ann Arbor, MI
Behavioral & Nutritional Treatment to Help CF Preschoolers Grow
A Multi-Site Randomized Clinical Trial of Behavioral and Nutrition Treatment Designed to Help Preschoolers With Cystic Fibrosis Optimize Growth
Status: Enrolling
Updated: 12/31/1969
University of Michigan Health System
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Behavioral & Nutritional Treatment to Help CF Preschoolers Grow
A Multi-Site Randomized Clinical Trial of Behavioral and Nutrition Treatment Designed to Help Preschoolers With Cystic Fibrosis Optimize Growth
Status: Enrolling
Updated:  12/31/1969
Rainbows and Babies Children's Hospital
mi
from
Cleveland, OH
Behavioral & Nutritional Treatment to Help CF Preschoolers Grow
A Multi-Site Randomized Clinical Trial of Behavioral and Nutrition Treatment Designed to Help Preschoolers With Cystic Fibrosis Optimize Growth
Status: Enrolling
Updated: 12/31/1969
Rainbows and Babies Children's Hospital
mi
from
Cleveland, OH
Click here to add this to my saved trials
Behavioral & Nutritional Treatment to Help CF Preschoolers Grow
A Multi-Site Randomized Clinical Trial of Behavioral and Nutrition Treatment Designed to Help Preschoolers With Cystic Fibrosis Optimize Growth
Status: Enrolling
Updated:  12/31/1969
Nationwide Children's Hospital
mi
from
Columbus, OH
Behavioral & Nutritional Treatment to Help CF Preschoolers Grow
A Multi-Site Randomized Clinical Trial of Behavioral and Nutrition Treatment Designed to Help Preschoolers With Cystic Fibrosis Optimize Growth
Status: Enrolling
Updated: 12/31/1969
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
RSV Disease in the Elderly
Pathogenesis of RSV Disease in the Elderly
Status: Enrolling
Updated:  12/31/1969
Rochester General Hospital
mi
from
Rochester, NY
RSV Disease in the Elderly
Pathogenesis of RSV Disease in the Elderly
Status: Enrolling
Updated: 12/31/1969
Rochester General Hospital
mi
from
Rochester, NY
Click here to add this to my saved trials
Treatment of Heroin and Cocaine With Methadone Maintenance and Contingency Management
Treatment of Heroin and Cocaine With Methadone Maintenance and Contingency Management
Status: Enrolling
Updated:  12/31/1969
National Institute on Drug Abuse
mi
from
Baltimore, MD
Treatment of Heroin and Cocaine With Methadone Maintenance and Contingency Management
Treatment of Heroin and Cocaine With Methadone Maintenance and Contingency Management
Status: Enrolling
Updated: 12/31/1969
National Institute on Drug Abuse
mi
from
Baltimore, MD
Click here to add this to my saved trials
Comparison Study of High Frequency Percussive Ventilation With Conventional Ventilation
A Prospective Randomized Controlled Trial Comparing High Frequency Percussive Ventilation With Conventional Mechanical Ventilation Utilizing Protective Lung Strategies in Patients With Acute Lung Injury/Acute Respiratory Distress Syndrome
Status: Enrolling
Updated:  12/31/1969
Parkland Health and Hospital System
mi
from
Dallas, TX
Comparison Study of High Frequency Percussive Ventilation With Conventional Ventilation
A Prospective Randomized Controlled Trial Comparing High Frequency Percussive Ventilation With Conventional Mechanical Ventilation Utilizing Protective Lung Strategies in Patients With Acute Lung Injury/Acute Respiratory Distress Syndrome
Status: Enrolling
Updated: 12/31/1969
Parkland Health and Hospital System
mi
from
Dallas, TX
Click here to add this to my saved trials
Rare Genetic Disorders of the Breathing Airways
Rare Genetic Disorders of the Airways: Cross-sectional Comparison of Clinical Features, and Development of Novel Screening and Genetic Tests
Status: Enrolling
Updated:  12/31/1969
The Children's Hospital
mi
from
Denver, CO
Rare Genetic Disorders of the Breathing Airways
Rare Genetic Disorders of the Airways: Cross-sectional Comparison of Clinical Features, and Development of Novel Screening and Genetic Tests
Status: Enrolling
Updated: 12/31/1969
The Children's Hospital
mi
from
Denver, CO
Click here to add this to my saved trials
Rare Genetic Disorders of the Breathing Airways
Rare Genetic Disorders of the Airways: Cross-sectional Comparison of Clinical Features, and Development of Novel Screening and Genetic Tests
Status: Enrolling
Updated:  12/31/1969
National Jewish Health
mi
from
Denver, CO
Rare Genetic Disorders of the Breathing Airways
Rare Genetic Disorders of the Airways: Cross-sectional Comparison of Clinical Features, and Development of Novel Screening and Genetic Tests
Status: Enrolling
Updated: 12/31/1969
National Jewish Health
mi
from
Denver, CO
Click here to add this to my saved trials
Rare Genetic Disorders of the Breathing Airways
Rare Genetic Disorders of the Airways: Cross-sectional Comparison of Clinical Features, and Development of Novel Screening and Genetic Tests
Status: Enrolling
Updated:  12/31/1969
Laboratory of Clinical Infectious Diseases, NIAID
mi
from
Bethesda, MD
Rare Genetic Disorders of the Breathing Airways
Rare Genetic Disorders of the Airways: Cross-sectional Comparison of Clinical Features, and Development of Novel Screening and Genetic Tests
Status: Enrolling
Updated: 12/31/1969
Laboratory of Clinical Infectious Diseases, NIAID
mi
from
Bethesda, MD
Click here to add this to my saved trials
Rare Genetic Disorders of the Breathing Airways
Rare Genetic Disorders of the Airways: Cross-sectional Comparison of Clinical Features, and Development of Novel Screening and Genetic Tests
Status: Enrolling
Updated:  12/31/1969
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Rare Genetic Disorders of the Breathing Airways
Rare Genetic Disorders of the Airways: Cross-sectional Comparison of Clinical Features, and Development of Novel Screening and Genetic Tests
Status: Enrolling
Updated: 12/31/1969
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Rare Genetic Disorders of the Breathing Airways
Rare Genetic Disorders of the Airways: Cross-sectional Comparison of Clinical Features, and Development of Novel Screening and Genetic Tests
Status: Enrolling
Updated:  12/31/1969
Children's Hospital and Regional Medical Center
mi
from
Seattle, WA
Rare Genetic Disorders of the Breathing Airways
Rare Genetic Disorders of the Airways: Cross-sectional Comparison of Clinical Features, and Development of Novel Screening and Genetic Tests
Status: Enrolling
Updated: 12/31/1969
Children's Hospital and Regional Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Rare Genetic Disorders of the Breathing Airways
Rare Genetic Disorders of the Airways: Cross-sectional Comparison of Clinical Features, and Development of Novel Screening and Genetic Tests
Status: Enrolling
Updated:  12/31/1969
Stanford University
mi
from
Palo Alto, CA
Rare Genetic Disorders of the Breathing Airways
Rare Genetic Disorders of the Airways: Cross-sectional Comparison of Clinical Features, and Development of Novel Screening and Genetic Tests
Status: Enrolling
Updated: 12/31/1969
Stanford University
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Rare Genetic Disorders of the Breathing Airways
Rare Genetic Disorders of the Airways: Cross-sectional Comparison of Clinical Features, and Development of Novel Screening and Genetic Tests
Status: Enrolling
Updated:  12/31/1969
St. Michael's Hospital
mi
from
Toronto,
Rare Genetic Disorders of the Breathing Airways
Rare Genetic Disorders of the Airways: Cross-sectional Comparison of Clinical Features, and Development of Novel Screening and Genetic Tests
Status: Enrolling
Updated: 12/31/1969
St. Michael's Hospital
mi
from
Toronto,
Click here to add this to my saved trials
Rare Genetic Disorders of the Breathing Airways
Rare Genetic Disorders of the Airways: Cross-sectional Comparison of Clinical Features, and Development of Novel Screening and Genetic Tests
Status: Enrolling
Updated:  12/31/1969
Washington University
mi
from
Saint Louis, MO
Rare Genetic Disorders of the Breathing Airways
Rare Genetic Disorders of the Airways: Cross-sectional Comparison of Clinical Features, and Development of Novel Screening and Genetic Tests
Status: Enrolling
Updated: 12/31/1969
Washington University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases
Role of Helicobacter Pylori and Its Toxins in Pulmonary and Oropharyngeal Disease
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases
Role of Helicobacter Pylori and Its Toxins in Pulmonary and Oropharyngeal Disease
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Genetic Disorders of Mucociliary Clearance in Nontuberculous Mycobacterial Lung Disease
Genetic Disorders of Mucociliary Clearance
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Genetic Disorders of Mucociliary Clearance in Nontuberculous Mycobacterial Lung Disease
Genetic Disorders of Mucociliary Clearance
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Nasal Epithelial Cells/Blood Lymphocyte Markers for Cystic Fibrosis (CF)/CF Pulmonary Exacerbations
Use of Nasal Epithelial Cells and Blood Lymphocytes to Identify Markers for Cystic Fibrosis and Cystic Fibrosis Pulmonary Exacerbations
Status: Enrolling
Updated:  12/31/1969
Rainbow Babies and Children's Hospital
mi
from
Cleveland, OH
Nasal Epithelial Cells/Blood Lymphocyte Markers for Cystic Fibrosis (CF)/CF Pulmonary Exacerbations
Use of Nasal Epithelial Cells and Blood Lymphocytes to Identify Markers for Cystic Fibrosis and Cystic Fibrosis Pulmonary Exacerbations
Status: Enrolling
Updated: 12/31/1969
Rainbow Babies and Children's Hospital
mi
from
Cleveland, OH
Click here to add this to my saved trials
Treatment of Children With Obstructive Sleep Apnea and Laryngomalacia: the Role of Laser Supraglottoplasty
Treatment of Children With Obstructive Sleep Apnea and Laryngomalacia: the Role of Laser Supraglottoplasty
Status: Enrolling
Updated:  12/31/1969
Riley Children's Hospital
mi
from
Indianapolis, IN
Treatment of Children With Obstructive Sleep Apnea and Laryngomalacia: the Role of Laser Supraglottoplasty
Treatment of Children With Obstructive Sleep Apnea and Laryngomalacia: the Role of Laser Supraglottoplasty
Status: Enrolling
Updated: 12/31/1969
Riley Children's Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi.
Status: Enrolling
Updated:  12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi.
Status: Enrolling
Updated: 12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi.
Status: Enrolling
Updated:  12/31/1969
University of Chicago, Division of Infectious Diseases
mi
from
Chicago, IL
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi.
Status: Enrolling
Updated: 12/31/1969
University of Chicago, Division of Infectious Diseases
mi
from
Chicago, IL
Click here to add this to my saved trials
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi.
Status: Enrolling
Updated:  12/31/1969
Indiana BMT
mi
from
Springfield, IL
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi.
Status: Enrolling
Updated: 12/31/1969
Indiana BMT
mi
from
Springfield, IL
Click here to add this to my saved trials
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi.
Status: Enrolling
Updated:  12/31/1969
Infectious Disease of Indiana
mi
from
Indianapolis, IN
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi.
Status: Enrolling
Updated: 12/31/1969
Infectious Disease of Indiana
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi.
Status: Enrolling
Updated:  12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi.
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi.
Status: Enrolling
Updated:  12/31/1969
Upstate Infectious Diseases Association LLP
mi
from
Albany, NY
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi.
Status: Enrolling
Updated: 12/31/1969
Upstate Infectious Diseases Association LLP
mi
from
Albany, NY
Click here to add this to my saved trials
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi.
Status: Enrolling
Updated:  12/31/1969
Regional Infection Diseases Infusion Center Inc.
mi
from
Lima, OH
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi.
Status: Enrolling
Updated: 12/31/1969
Regional Infection Diseases Infusion Center Inc.
mi
from
Lima, OH
Click here to add this to my saved trials
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi.
Status: Enrolling
Updated:  12/31/1969
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi.
Status: Enrolling
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi.
Status: Enrolling
Updated:  12/31/1969
University of Alabama
mi
from
Birmingham, AL
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi.
Status: Enrolling
Updated: 12/31/1969
University of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi.
Status: Enrolling
Updated:  12/31/1969
Springfield Clinic, LLP
mi
from
Springfield, IL
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi.
Status: Enrolling
Updated: 12/31/1969
Springfield Clinic, LLP
mi
from
Springfield, IL
Click here to add this to my saved trials
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi.
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Worcester, MA
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Worcester, MA
Click here to add this to my saved trials
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi.
Status: Enrolling
Updated:  12/31/1969
mi
from
Buenos Aires,
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi.
Status: Enrolling
Updated: 12/31/1969
mi
from
Buenos Aires,
Click here to add this to my saved trials
A Placebo-Controlled Study of Mixed Amphetamine Salts and Topiramate for the Treatment of Cocaine Dependence
A Randomized, Double-Blind, Placebo-Controlled Study of Mixed Amphetamine Salts (Adderall-XR) and Topiramate for the Treatment of Cocaine Dependence
Status: Enrolling
Updated:  12/31/1969
STARS
mi
from
New York, NY
A Placebo-Controlled Study of Mixed Amphetamine Salts and Topiramate for the Treatment of Cocaine Dependence
A Randomized, Double-Blind, Placebo-Controlled Study of Mixed Amphetamine Salts (Adderall-XR) and Topiramate for the Treatment of Cocaine Dependence
Status: Enrolling
Updated: 12/31/1969
STARS
mi
from
New York, NY
Click here to add this to my saved trials
Acoustic Startle Reduction In Cocaine Dependence
Acoustic Startle Reduction In Cocaine Dependence
Status: Enrolling
Updated:  12/31/1969
Atlanta Veterans Adminstration Medical Center
mi
from
Decatur, GA
Acoustic Startle Reduction In Cocaine Dependence
Acoustic Startle Reduction In Cocaine Dependence
Status: Enrolling
Updated: 12/31/1969
Atlanta Veterans Adminstration Medical Center
mi
from
Decatur, GA
Click here to add this to my saved trials
Enhancing Utilization of Non-Invasive Positive Pressure Ventilation in Critical Care
Enhancing Utilization of Non-Invasive Positive Pressure Ventilation in Critical Care
Status: Enrolling
Updated:  12/31/1969
Tufts Medical Center
mi
from
Boston, MA
Enhancing Utilization of Non-Invasive Positive Pressure Ventilation in Critical Care
Enhancing Utilization of Non-Invasive Positive Pressure Ventilation in Critical Care
Status: Enrolling
Updated: 12/31/1969
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials